People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses

Authors

Lapointe, H.R., Mwimanzi, F., Cheung, P.K., Sang, Y., Yaseen, F., Umviligihozo, G., Kalikawe, R., Speckmaier, S., Moran-Garcia, N., Datwani, S., Duncan, M.C., Agafitei, O., Ennis, S., Young, L., Ali, H., Ganase, B., Omondi, F.H., Dong, W., Toy, J., Sereda, P., Burns, L., Costiniuk, C.T., Cooper, C., Anis, A.H., Leung, V., Holmes, D.T., DeMarco, M.L., Simons, J., Hedgcock, M., Prystajecky, N., Lowe, C.F., Pantophlet, R., Romney, M.G., Barrios, R., Guillemi, S., Brumme, C.J., Montaner, J.S.G., Hull, M., Harris, M., Niikura, M., Brockman, M.A., Brumme, Z.L.